John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 20,312 shares at $21.03 ($427K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Scheduled sale ($427k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.03 | 10,156 | $214K | 50.0% |
| 2 | $21.03 | 10,156 | $214K | 50.0% |
| Total | $21.03 avg | 20,312 | $427K | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |